Bacterial Infections
Welcome,         Profile    Billing    Logout  
 127 Companies   123 Products   123 Products   59 Mechanisms of Action   6 Trials   3245 News 


«12...2627282930313233343536...6566»
  • ||||||||||  Menactra (Meningococcal-groups A, C, Y and W-135 polysaccharide diphtheria toxoid conjugate vaccine) / Sanofi
    Trial completion, Enrollment change, Trial initiation date, Trial primary completion date:  36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds (clinicaltrials.gov) -  Feb 12, 2015   
    P=N/A,  N=1421, Completed, 
    Recruiting --> Completed | N=100 --> 36 | Trial primary completion date: Jun 2012 --> Oct 2012 Active, not recruiting --> Completed | N=1906 --> 1421 | Initiation date: Jul 2008 --> Jul 2005 | Trial primary completion date: Nov 2013 --> May 2013
  • ||||||||||  rifampicin/isoniazid/ethambutol/pyrazinamide / Generic mfg.
    Enrollment change, Trial initiation date, Trial primary completion date:  Essentiality of INH in TB Therapy (clinicaltrials.gov) -  Feb 11, 2015   
    P2a,  N=60, Not yet recruiting, 
    Trial primary completion date: Nov 2014 --> Nov 2015 N=45 --> 60 | Initiation date: Jul 2014 --> Apr 2015 | Trial primary completion date: May 2015 --> Sep 2015
  • ||||||||||  Enrollment open, Trial primary completion date:  Evaluation of Enhanced Syphilis Screening Among HIV-positive Men (clinicaltrials.gov) -  Feb 6, 2015   
    P=N/A,  N=3131, Recruiting, 
    Trial primary completion date: Jan 2015 --> Jul 2015 Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2016 --> Jul 2017
  • ||||||||||  afabicin IV (Debio 1450 IV) / Debiopharm, afabicin oral (Debio 1450) / Debiopharm
    Clinical:  A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers (clinicaltrials.gov) -  Feb 6, 2015   
    P1,  N=60, Active, not recruiting, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2016 --> Jul 2017 Recruiting --> Active, not recruiting
  • ||||||||||  TicoVac (tick-borne encephalitis vaccine, whole Virus inactivated) / Pfizer
    Trial primary completion date:  Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) (clinicaltrials.gov) -  Feb 3, 2015   
    P2,  N=160, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> May 2015 Trial primary completion date: Jan 2020 --> Jan 2030
  • ||||||||||  Enrollment open, Enrollment change, Trial initiation date, Trial primary completion date:  Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults (clinicaltrials.gov) -  Jan 30, 2015   
    P1,  N=42, Recruiting, 
    Recruiting --> Completed | N=90 --> 36 Active, not recruiting --> Recruiting | N=30 --> 42 | Initiation date: Apr 2013 --> Jul 2013 | Trial primary completion date: Aug 2014 --> Jan 2016
  • ||||||||||  aztreonam / Generic mfg., vancomycin / Generic mfg., ceftaroline fosamil / Generic mfg.
    Trial termination, Trial primary completion date:  Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. (clinicaltrials.gov) -  Jan 29, 2015   
    P3,  N=60, Terminated, 
    Trial primary completion date: Feb 2016 --> Oct 2016 Recruiting --> Terminated | Trial primary completion date: Aug 2015 --> Jan 2015; Overall study status is changed to "Terminated" due to low enrollment
  • ||||||||||  Pneumovax 23 (23-valent pneumococcal polysaccharide) / Merck (MSD)
    Phase classification, Pneumococcal vaccines:  A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) (clinicaltrials.gov) -  Jan 29, 2015   
    P3,  N=130, Completed, 
    Recruiting --> Terminated | Trial primary completion date: Aug 2015 --> Jan 2015; Overall study status is changed to "Terminated" due to low enrollment Phase classification: P1 --> P3
  • ||||||||||  Trial primary completion date:  Prevention of GBS Colonization Via Immunity (clinicaltrials.gov) -  Jan 28, 2015   
    P2,  N=667, Completed, 
    Trial primary completion date: Oct 2014 --> Jul 2015 Trial primary completion date: Feb 2008 --> Dec 2008
  • ||||||||||  Enrollment open, Enrollment change, Trial primary completion date:  Peristeen Bowel Irrigation System in Cauda Equina (clinicaltrials.gov) -  Jan 28, 2015   
    P=N/A,  N=15, Recruiting, 
    Trial primary completion date: Feb 2008 --> Dec 2008 Active, not recruiting --> Recruiting | N=10 --> 15 | Trial primary completion date: Dec 2014 --> Aug 2015
  • ||||||||||  Enrollment change:  Expression of Tuberculosis in the Lung (clinicaltrials.gov) -  Jan 26, 2015   
    P=N/A,  N=40, Completed, 
    Recruiting --> Completed | N=103 --> 124 N=150 --> 40
  • ||||||||||  Enrollment closed:  Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ. (clinicaltrials.gov) -  Jan 26, 2015   
    P3,  N=55, Active, not recruiting, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2014 --> Apr 2015 Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion:  Prevention of GBS Colonization Via Immunity (clinicaltrials.gov) -  Jan 26, 2015   
    P2,  N=667, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Feb 2016 Active, not recruiting --> Completed
  • ||||||||||  pretomanid (PA-824) / Global Alliance for TB Drug Development
    New P3 trial:  STAND: Shortening Treatment by Advancing Novel Drugs (clinicaltrials.gov) -  Jan 22, 2015   
    P3,  N=1500, Not yet recruiting,